Skip to main content
. 2022 Oct 10;12:1018285. doi: 10.3389/fonc.2022.1018285

Figure 6.

Figure 6

Identification of prognostic indicators for bladder cancer in training set. (A) The risk score curve, survival status and ceRNA-associated prognosis model gene expression heatmap were displayed from top to bottom in the TCGA_BLCA training cohort. The abscissa axis of these graphs were ranked by the risk score value. (B, C) Correlation between riskscore group and clinicopathological data of BCa patients via Wilcox rank test or Chi-square test. (D) The risk score was independent risk factors for bladder cancer. (E) Construction of a ceRNA-associated gene signature combined with clinical features nomogram. (F) Calibration curve of nomogram. (G) A multi-index ROC curve demonstrated the good discriminative abilities of the ceRNA-associated gene signature or nomograms. (H) DCA was applied to render clinical validity to the constructed gene signature or nomograms. ceRNA, competing endogenous RNA; BCa, bladder cancer; ROC, receiver operating characteristic; DCA, decision curve analysis. *P < 0.05, **P < 0.01 and ***P < 0.001.